| Title |
Tech ID # |
|
Anti-CD79 Antibody Offers Novel Approach to Therapy in Autoimmune Disease,
Transplantation and Lymphoma
|
11-15 |
| PTPN13: A Novel Target for the Treatment of Pulmonary Fibrosis |
11-09 |
| Novel PIM 1 Kinase Inhibitor that Upregulates RUNX3 for the Treatment of Allergic Diseases |
11-06 |
| Novel Adjuvant for Increasing Effectiveness of Vaccines |
10-13 |
| Use of the Listeria Monocytogenes p60 Polypeptide and Variants for Stimulating NK cells |
10-08 |
| Targeting FgfR2b for the Treatment of Adult Lung Injury |
09-20 |
| SERCA2: Novel Target for the Treatment of Cystic Fibrosis |
09-05
|
| Targeting a Subset of B Cells to Treat Autoimmune Diseases |
09-03 |
| Adenosine A2A Receptor: A Prognosis Marker for Lung Cancer |
08-11
|
| Novel TLR Inhibitors Prevent Respiratory Syncytial Virus Infection In Vivo |
07-07
|
| Treatment with an Antibody Against VGamma4 T Cells Reduces Rheumatoid Arthritis Symptoms in Mice |
07-06
|
| MAGP-2: An extracellular factor shown to have pro-angiogenic properties in vivo |
06-05
|
| Method to prevent biofilm formation in various clinical settings (contact lenses, wounds, cystic fibrosis, etc.) |
04-08
|
| Cystatin C: an extracellular antagonist of the TGF beta receptor. Potential therapies for cancer and fibrotic diseases |
04-05
|
| Modulating the transport of thiol-containing molecules for the treatment of lung disease and cancer |
02-16
|
| Liposomal clodronate as a therapy for autoimmune hemolytic anemia |
02-07
|
| High-throughput cell based assay for the identification of drugs targeting the NF-kB signaling pathway |
02-05
|
Novel molecular targets for anti-inflammatory drug development:
- TALL-1: A member of the TNF gene family
- TALL-1 receptor (BCMA)
- TALL-1 and receptors 3D structure |
02-01 |
| Use of aerosolized anti-TCR monoclonal antibodies as a therapy for airway hyperresponsiveness |
01-01
|
| Calcitonin Gene-Related Peptide For The Reduction Of Allergen-Induced Airway Hyperresponsiveness |
00-14
|
| Cdk6 as a marker for breast cancer |
00-11
|
| New Agar Medium for the Isolation and Testing Susceptibility of Mycobacterium Tuberculosis Against Drugs |
00-05
|
| Peptides offer strategies for novel immunosuppressants and anti-herpes agents |
96-02
|
| Method to Produce Monoclonal Antibodies to Human T-Cell Receptor Elements |
91-02
|
